chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reports within week or 2 of Dose #1  vaccination severe stomach cramping and diarrhea regularly almost every other day.  Then subsided.  After receiving 2nd dose more diarrhea and continued until he discovered that EGGS caused/made worse the issues.   Patient stated he ate eggs ALL the time prior to vaccination with no problem ever, however after vaccination he can NO LONGER eat eggs without diarrhea although the cramping is not as bad as it was initially.  He now feels he has a severe egg "allergy" or more specifically "intollerance" that he never had prior to vaccination.
Feeling unwell; Shaking; Throat swollen shut; Low Blood Pressure; Weak Knees; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling unwell), TREMOR (Shaking), PHARYNGEAL SWELLING (Throat swollen shut), HYPOTENSION (Low Blood Pressure) and ARTHRALGIA (Weak Knees) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History reported.  Concomitant products included PREGABALIN (LYRICA), TYROSINE, DULOXETINE HYDROCHLORIDE (CYMBALTA), AMOXICILLIN TRIHYDRATE, CLARITHROMYCIN, ESOMEPRAZOLE MAGNESIUM (NEXIUM 1-2-3), POTASSIUM CHLORIDE (KLOR-CON), NEBIVOLOL HYDROCHLORIDE (BYSTOLIC), CELECOXIB (CELEBREX), FEXOFENADINE HYDROCHLORIDE (ALLEGRA), CLONAZEPAM, LINAGLIPTIN (TRADJENTA) and CYPROHEPTADINE HYDROCHLORIDE (PERIACTIN) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced MALAISE (Feeling unwell), TREMOR (Shaking), PHARYNGEAL SWELLING (Throat swollen shut), HYPOTENSION (Low Blood Pressure) and ARTHRALGIA (Weak Knees). On 11-Mar-2021, TREMOR (Shaking), PHARYNGEAL SWELLING (Throat swollen shut) and ARTHRALGIA (Weak Knees) had resolved. On 17-Mar-2021, MALAISE (Feeling unwell) and HYPOTENSION (Low Blood Pressure) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient states vaccination was given at top of shoulder and caused tendon pain which she is currently being treated for. Informed Pharmacist on 11/10/2010.
Narrative:  Pt is a 74 y/o male with diagnosis listed as Parkinson's Disease & Dementia. Pt received both covid vaccine vaccinations on 1/6/21 & 2/3/21. Pt passed away on 5/17/2021 while outpatient. No further information available about his death. Unable to assess if death is related to covid vaccinations.
This spontaneous report was received from a Licensed Practical Nurse refers to unspecified number of unknown age and gender patients. The nurse reported that improperly stored GARDASIL (lot# unspecified) (dose, route and location unspecified) might have been administered (exact dates of administration unspecified) the GARDASIL was improperly stored in June of 2013, exact date of improper storage was unspecified). No adverse event reported. This is one of several reports received from the same source. Additional information has been requested.
Patient had 6-10 loose stools per day with increase in fussiness and gas that lasted 6 days. Symptoms began the night of 10/20/06.
Site was sore for 2 days, then it began to swell and was red at warm to the touch. She stated severe itching. She went to the doctor on 10/30 and was prescribed Medrol dosepak. When she came to pic up the prescription, her arm was no longer swollen but was red from around the injection site to the elbow. She stated the itching had improved and it was no longer warm to the touch.
Syncope - lasting 15 seconds (with stiffening but no seizures) resolved spontaneously with conservative care (lying down).
This employee inadvertently received an injection of improperly stored vax which had been left out of refrigeration for one day. The pt developed flu-like symptoms which consisted of a cold, aches, and diarrhea. The pt recovered.
Hospitalization 1/20/22-1/22/22 Abnormal coagulation profile,  2 Re-admits for COVID as well.
I had my 2nd vaccine on 01/06/2021 and where the injection was done is now a big red spot around the area and has spread a tiny bit and it's warm to the touch with a hard bump. No other symptoms, except tired. no fever ect
4 lesions on chest and ear. They look like Chickenpox.; 4 lesions on chest and ear. They look like Chickenpox.; This case was reported by a consumer via interactive digital media and described the occurrence of skin lesion in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 6th October 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced skin lesion and varicella-like rash. On an unknown date, the outcome of the skin lesion and varicella-like rash were unknown.   It was unknown if the reporter considered the skin lesion and varicella-like rash to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The age group was captured as an adult as per vaccine indication. The patient developed 4 lesions on chest and ear. They look like chickenpox.  The patient wanted to know if he/she should get second dose. The reporter consented to follow up.
Approximately 3 hours post vax, doctor's office received a call from parents that pt had developed hives, red, itchy eyes and wheezing. Parents treated pt with dose of Atarax and nebulizer treatment of Albuterol and Intal. Pt's symptoms subsided by 10 PM the same evening and did not recur.
Initial report received from a health care professional on 24 September 2007. A female patient developed a large local reaction at the site of injection and was diagnosed with cellulitis, after she received Adacel (lot number C2770AA) in the right deltoid. Meningococcal vaccine (manufacturer sanofi pasteur, lot number "U23816A") in the left deltoid and HPV vaccine (Merck, lot number 0927U) in the left deltoid. She did not have any illness at the time of the vaccinations. It was reported the patient recovered. This case has the same reporter as cases 2007-02774 and 2007-03221.
Patient was given a vaccine that was beyond it's use date of 7/22/2022.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. In approximately 2016 (since 08-FEB-2016), the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # L019297, expiration date 18-AUG-2017; lot # L043214, expiration date 30-AUG-2017; lot # M003659, expiration date 20-SEP-2017; lot # M005714, expiration date 03-OCT-2017 (dose and route of administration were not reported). There was no adverse effect reported. Administered does of vaccine experienced the temperature excursion of 9 degrees Celsius for 9 hours, 0.3 degrees Celsius for 837 hours and 30 degrees Fahrenheit for 542 hours. This is one of several reports received from the same reporter. Additional information has been requested.
The pt experienced nausea, vomiting (1 time) diarrhea (1 time) occurring 3-4 hours post vax.
Approx. 4 hours, post vax, the pt exhibited rash, progressing to labored breathing and bradycardia. Pt became cyanotic, required PALS intervention of positive present O2, Epinephrine, Benadryl, IV access and transport to hospital. Pt improved with treatment. Allergy evaluation completed one month post event ruled out an allergic response to DTaP, strongly doubted reaction to Prevnar-that vaccine wasn't available for testing- and concluded a strong allergic response to the caseine in the Similac.
Pt received her 1st does of Moderna Covid 19 vaccine on 02/9/21 at another facility. A week afterwards developed itching at site. Mild pain in upper arm. Area of erythema on upper arm Some raised papules on the border with untrue clearing
Patient received single dose vaccine of Janssen / Johnson and Johnson Covid-19 vaccine to R deltoid on 15 MAR 2021 and presented to clinic here on 18 MAR 2021 with excess left shoulder pain (2/10 rest but increased with active range of motion) and slight limitation in range of motion to R shoulder due to pain
Admission Date: 9/19/2022 Discharge Date: 9/25/2022  PRESENTING PROBLEM: COVID-19 [U07.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE:  Patient is a very pleasantly confused 80-year-old gentleman who presented with weakness and confusion on admission in the setting of advanced dementia, diabetes mellitus type 2, hypertension.  The patient was diagnosed with COVID-19 infection.  And was in isolation per hospital protocol.  It was also noted that patient drank about 4-5 drinks of whiskey per day.  Patient mentation waxed and waned.  He did not require any supplemental oxygen or required additional treatment per hospital protocol.  Patient was placed on CIWA protocol.  Patient initially was given high-dose thiamine given his heavy alcohol use with no effect.  Care manager was working with family to secure a rehab that will accept a COVID patient with hopes of bringing the patient back home.  Given patient's dementia and comorbidities palliative Care was called to talk to family and will follow-up when patient returns home.  Currently his wife is taking care of him however she also has COVID and he was more than she could handle at that time but they do wish that patient would be able to return home.  Chest x-ray did show left basilar opacities and we will repeat that chest x-ray.  We will discharge the patient on Ceftin and doxycycline to complete a 5 day course.  Patient had elevated AST 19-- >159-- >104.  Patient had elevated ALT 15-- >152-- >126.  Needs to be monitored by SAR and PCP.  Further workup is needed outpatient.  Patient's family was updated by care manager.  Patient was accepted into a COVID facility for rehab.  Patient was discharged in good condition.   His anticipated discharge is 830 on September 25, 2022
LOW GRADE FEVER - TYLENOL AND IBUPROFEN WITH MILD SUCCESS (LASTED 2 DAYS STARTED 10 HOURS AFTER SHOT) CHILLS - TYLENOL AND IBUPROFEN WITH MILD SUCCESS (LASTED 2 DAYS STARTED 10 HOURS AFTER SHOT) TIRED/WEAK - NO TREATMENT (STARTED 10 HOURS AFTER AND LASTED 2 DAYS AFTER SHOT) EAR ACHE - TYLENOL AND IBUPROFEN WITH LITTLE SUCCESS (STARTED 10 HOURS AFTER AND LASTED 2 DAYS AFTER SHOT)
Body aches; Chills; 102.3 fever; Fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration on 30Mar2021 at 12:15 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration on 09Mar2021 at 11:30 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, the patient experienced body aches, chills, 102.3 fever, fatigue and headache. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events body aches, chills, 102.3 fever, fatigue and headache. The clinical outcomes of the events body aches, chills, 102.3 fever, fatigue and headache were resolved on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
6/21/2023 - 6/24/2023 (3 days) presented to the ED with complaints of generalized weakness, worsening shortness of breath upon inspiration over the past few days without fever/chills. Patient did report sharp like, moderate intensity, central chest pain that is radiating to right side chest wall and worse upon deep inspiration.   Patient also reported some diarrhea, nausea and vomiting 1 day prior to ED presentation that self-resolved. 3/9/2021 EN6205  EP7534 3/30/2021  patient had a negative test the same day they had a positive one.
The patient came into the health department at approximately 1:00 PM for her last Rabies vaccine to complete the series of 3 doses. About 10 minutes after receiving the vaccine, the patient began to feel "light headed" and her face became flushed. She reported feeling a "tingling" sensation in her left arm that ran from the injection site in the deltoid all the way down her arm. At 1:10 the patient's blood pressure was 139/78, heart rate was 80. The patient reported a headache as well located to the frontal area and rated her pain a 3/10. Patient reports her left arm is still tingling and was provided with apple juice and reclined back in chair. Patient denies any history of allergies or previous reaction to Vitals taken at 1:20 PM: BP 132/78, HR 83. Patient reports continued headache and tingling in left arm. Bilateral grip to hand strong, no weakness noted. Patient is stable but states her vision is slightly blurry and she feels dizzy. At 13:30 the patient's blood pressure is 140/76, HR 74. Patient reports tinging sensation has slightly improved and headache is about the same. Patient reports history of anxiety attacks. Patient kept in office until 2:15 PM and was continuously monitored. At 2:15 the patients BP is 118/72 and she states her headache is a 1/10 on the pain scale. Left arm has no redness or edema. She reports some continued tingling in the Left arm. The patient stands with assistance and is monitored. No acute distress is noted. The patient's guardian came to pick up the patient and escort patient home. The patient was escorted out of the building by RN and gets in the vehicle with her guardian. Patient was instructed to go to ER or Urgent care if any symptoms change or worsen. Patient to see Doctor if tingling does not resolve.   4/26/19: Phone call made by RN to follow up with patient. Patient states all her symptoms have resolved and she returned to work today. Patient denies headache, dizziness, or tingling in left arm.
Headache; A spontaneous report was received from a consumer concerning a 71-year-old, male patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced headache.   The patient's medical history was provided. Concomitant medications were not reported.  On 19 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 11 Feb 2021, prior to receiving mRNA-1273, the patient felt headache. He contacted his HCP and due to the location of the headaches was told he should go to the hospital to rule out a stroke. He was admitted to the hospital and stayed for 2 days. He was started on 40mg of steroids prophylactically. Caller states many different tests were performed but an MRI ruled out a stroke. He was then allowed to taper off the steroids. Prior to hospitalization, he was scheduled to have his second Moderna COVID-19 vaccination on 15 FEB 2021. He consulted his neurologist who told him to go ahead with the vaccination even though he would not complete his steroid taper until 19 FEB 2021. He was advised to also have an antibody test done 2-3 weeks after the vaccination. He has received the lab results and believes it is negative, but is confused by the results.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of event headache was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Muscle pains and headache  (3 days), Fever (1 day - two days after vaccine administered), Chills or Shivering (1 day - followed fever), Tiredness and Upset Stomach (3 days - followed chills).  Had similar symptoms after the 1st Shingrix shot but not to the severity of this second shot.
UrticariaPruritus  Narrative:  Pt experienced itching and hives an hour after receiving covid vaccine, leading to ED visit and received IV famotidine.
4/9/21, just a sore arm and tired the same day  Day 2-2.5: tired and little headache, sore arm, some body aches  Monday &Tuesday (4/12/21 --4/13/21) Had to miss work. Temp 99 on 4/13. VERY fatigued. Unable to regulate body temp. Hot and cold. Joint pain., body aches, excessive thirst, brain fog.
Headache, Myalgia, NauseaVomiting, body aches nausea, tired , inj site arm pain low grade fever Narrative:
Arthralgia/ Joint pain; Myalgia; pain in right and left arm.; This case was reported by a pharmacist via call center representative and described the occurrence of arthralgia in a 82-year-old female patient who received Herpes zoster (Shingrix) (batch number ER5ZB, expiry date 9th June 2021) for prophylaxis.   The patient's past medical history included shingles (2 mild outbreaks 6 month before to vaccination).   On 27th February 2018, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced arthralgia, myalgia and pain in arm. The patient was treated with non-drug therapy (Physical Therapy (Nos)). Shingrix was discontinued. On an unknown date, the outcome of the arthralgia, myalgia and pain in arm were unknown.   It was unknown if the reporter considered the arthralgia, myalgia and pain in arm to be related to Shingrix.  Additional details were provided as follows: The patient reported arm pain in the right arm injection site that lasted for a month and moved to opposite arm, bilateral upper extremity joint pain, myalgia and arthralgia. The general practitioner discontinued vaccination therapy and patient was in physical therapy due to pain in joints. No additional information provided.
Pt recvd 2 doses Engerix-B 12SEP91 & 13NOV91; 1st dose uneventful; 7 hrs p/2nd vax pt devel pain in elbows & joints; progressed to numbness in hand & upper extremities, weakness- dx reticular neuropathy; dx polyneuropathy secondary to vax;
Vaccine came from punctured vial at room temp ~ 4 hours.  Data for punctured vial is only ok for 2 hours vs 6 hours for unpunctured vial.  Trying to get in touch with patient to advise to monitor for signs/symptoms of infection.
Vaccine administration error: Janssen COVID19 vaccine administered as second dose, only 13 days after initial dose of Pfizer COVID19 vaccine.  Patient developed tingling and numbness approx. 15 minutes following vaccine administration -- starting at the injection site and spreading to upper back, neck, right arm, and right flank -- and persisting approx. 12 hours.  Patient developed nodule 12mm nodule at injection site approx. 1 week post injection and persisting approx. 3 weeks.  Patient later contracted SARS-COV-2 with a moderate disease course.
Started 4/19/06 with vomiting after any feeding and had increased fussiness. This progressed to the point of not holding any formula and an intussusception was dx'd by a contrast enema on 4/21/06 and was reduced. 7/17/06 Received medical records from initial hospital for 2 dates: 4/20/06 seen for projectile vomiting & diarrhea for 2 days. Had been to PCP on 4/19 for same.  X-ray showed moderate dilation of colon.  KUB revealed ileus vs early mechanical obstruction.  Patient transferred for eval of intussception. 4/22/06 Patient was recalled to same ER for positive blood c/s which had been drawn in ER on 4/20.  Patient appeared well w/temp of 99.  CBC was WNL, blood c/s was repeated.  Given IM antibiotics & d/c to f/u with PCP following day.  Final blood c/s was no growth/ss 7/24/06 Received medical records from PCP which included D/C summary from both hospitals.  MD notes indicate patient was afebrile at time of vax w/vomiting & diarrhea.  Dx: gastroenteritis.  4/21/06 PCP had discussion with physician at 2nd hospital about reduction of intussception with air contrast enema./ss
pt recv vax & exp upper resp problems including difficulty breathing & swallowing, fatigue, weakness, h/a, fever, aching, some sinus problems & a rash on face; presented to ER or MD ofc;
Pt stated that he had a severely painful reaction in which he felt like his arm was paralyzed.
1st dose 07Apr2021, no 2nd dose yet; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (1st dose 07Apr2021, no 2nd dose yet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Sep-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (1st dose 07Apr2021, no 2nd dose yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (1st dose 07Apr2021, no 2nd dose yet) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment information was provided.
Redness, swelling and heat at site that subsequently spread from upper arm to wrist. Tender to touch. Hot/cold therapy. Ibuprofen for pain. Spoke to MD over the phone, medical attention sought as of yet.
Narrative: Per nurse; Patient is 54 yo female here today as nurse visit. she is alert and oriented x3, nad. She ambulates self with steady gait unassisted, she denies and chest pain, no sob, no n/v/d. Patient presents with left upper arm area warm and itching, red area measures 18cm x 13cm. She had shingrix dose #1 on 2/27. noticed the red area about one day ago as it became itchy. She denies any facial swelling, no swelling or enlarged lymph nodes in left arm   plan:  patient evaluated with MD. instructed to take Zyrtec until symptoms resolve.  if  rash spreads, or develop fever, or developes SOB to go to the ER for further evaluation Symptoms:   SkinRash & urticaria Treatme nt:CETIRIZINE N/A
has seen a lot of people with hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (has seen a lot of people with hives) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (has seen a lot of people with hives). At the time of the report, URTICARIA (has seen a lot of people with hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information was not provided by the reporter.                            Treatment information was not provided by the reporter.  Reporter had seen an allergist and he had seen a lot of people with hives. Reporter states there is a ton of people approximately 1,000 + members that are in the group on social media who are primarily women around the age of 40.